LHC165

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LHC165, covering 2024-06-20 to 2024-06-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies [Phase 1]

See pricing